Nitpick—Sovaldi was actually the third HCV drug discovered by Pharmasset; the first was R7138 (licensed to Roche) and the second was PSI-7851. This is a nitpick because Sovaldi (a/k/a PSI-7977) was a single-isomer tweak of PSI-7851.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.